Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,211

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,841

Class I recallsReasonable probability of serious health consequences

24,366

Class II recallsTemporary or medically reversible health consequences

2,892

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,073 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/frutas-y-hortalizas-del-sur-sa-expands-recalls-include-additional-lots-great-value-frozen-organicPublished October 2, 2026

Most affected stateHawaii 200 recalls mention this state

State: NH ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 3, 2026 ET

Summary (Year to date)

1,714 recalls have been announced year to date.
Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (297).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

FDA Recall Terminated Historical recordClass III

Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by: Patheon Inc., Whitby Operations, Ontario, Canada L1N 5Z5; Distributed by: Novartis Pharmaceuticals Corp., East Hanover, New Jersey 07936; NDC 0078-0436-05, UPC 3 0078-0436-05 2.

by Novartis Pharmaceuticals Corp.

Reason: Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.
Published: August 13, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Risperdal CONSTA (risperiDONE), 25 mg Dose Pack, Rx Only, Single Use Only Janssen Pharmaceuticals Inc., Titusville, NJ 08560 NDC 50458-306-11

by Janssen Pharmaceuticals, Inc.

Reason: Non-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sample
Published: August 13, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA, LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, NDC 64679-101-07.

by Wockhardt Usa Inc.

Reason: Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.
Published: August 13, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Soliris (eculizumab), 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6.

by Alexion Pharmaceuticals, Inc.

Reason: Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.
Published: August 13, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cephalexin Capsules, USP, 500 mg, packaged in a) 100-count bottles (NDC 62756-294-88) and b) 500-count bottles (NDC 62756-294-13), Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Acme Plaza, Andheri-Kurla Road, Andheri (East), Mumbai-400 059, India.

by Caraco Pharmaceutical Laboratories, Ltd.

Reason: CGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good manufacturing practices.
Published: August 13, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cephalexin Capsules, USP, 250 mg, packaged in a) 100-count bottles (NDC 62756-293-88) and b) 500-count bottles (NDC 62756-293-13), Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Acme Plaza, Andheri-Kurla Road, Andheri (East), Mumbai-400 059, India.

by Caraco Pharmaceutical Laboratories, Ltd.

Reason: CGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good manufacturing practices.
Published: August 13, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP, 0.25mg, Rx only, 1000 tablets, Sandoz Inc., Princeton, NJ --- NDC 0781-1061-10

by Sandoz Incorporated

Reason: Presence of Foreign Substance; tablets may contain stainless steel metal particulates
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/25 mg, 30 and 90 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-107-30 and NDC 65597-107-90

by Daiichi Sankyo Pharma Development

Reason: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/12.5 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-106-30

by Daiichi Sankyo Pharma Development

Reason: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Benicar Tablets (olmesartan medoxomil) 40 mg, 30 and 90 count, Rx Only Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-104-30 and 65597-104-90

by Daiichi Sankyo Pharma Development

Reason: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Welchol Tablets (colesevelam HCl) 625 mg, 180 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 ---NDC 65597-701-18

by Daiichi Sankyo Pharma Development

Reason: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Tribenzor Tablets (olmesartan medoxomil/amlodipine/hydrochlorothiazide), 40 mg/5 mg*/25 mg 30 count bottles, Rx Only Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-116-30

by Daiichi Sankyo Pharma Development

Reason: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Benicar HCT Tablets (olmesartan medoxomil, hydrochlorothiazide) 20 mg/12.5 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-105-30

by Daiichi Sankyo Pharma Development

Reason: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Benicar Tablets (olmesartan medoxomil) 20 mg, 30 and 90 count, Rx Only Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-103-30 and NDC 65597-103-90

by Daiichi Sankyo Pharma Development

Reason: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc. Parsippany, NJ 07054 NDC 65597-113-30

by Daiichi Sankyo Pharma Development

Reason: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90

by Jubilant Cadista Pharmaceuticals Inc.

Reason: Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

triple therapy, LANSOPRAZOLE DR Capsules USP 30mg, CLARITHROMYCIN Tablets USP 500mg, AMOXICILLIN Capsules USP 500mg, 8 count Blister Pack Lansoprazole DR Capsules USP & Clarithromycin Tablets USP, MANUFACTURED Israel for Teva Pharmaceuticals USA, Sellersville, PA 18960, Amoxicillin Capsules USP manufactured in Canada, for Teva Pharmaceuticals USA, Sellersville, PA 18960. NDC# 0093-8055-78

by Teva Pharmaceuticals USA

Reason: Failed Impurities/Degradation Specifications: This recall is due to out of specification for impurities test results obtained during stability testing for Lansoprazole.
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fagron, Pentravan Plus Base 2.5 Kg, Article number: 804749. RX only, For prescription compounding, Oil-in-water emulsion base alternative to PLO gel, Added emulsifier ad viscosity-enhancing agent for use with high concentrations of active ingredients.Pre served and fragrance-free, Manufactured by: Fagron, Inc. 2400 Pilot Knob Rd, St. Paul, MN 55120, NDC 51552-1285-8,

by Fagron, Inc

Reason: Microbial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fagron, Pentravan Base 2.5 Kg, Article number: 802486. RX only, For prescription compounding, Oil-in-water emulsion, PLO gel alternative, Preserved and fragrance-free, Manufactured by; Fagron, Inc. 2400 Pilot Knob Rd, St. Paul, MN 55120 NDC 51552-0919-8.

by Fagron, Inc

Reason: Microbial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.
Published: August 6, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fagron, Phytobase Cream, 500 g, Article number: 802156. RX only, For prescription compounding Natural self-emulsifying oil-in water vehicle for oil-solvents ingredients. Contains Phytosomes (Plant Oil Bodies), Manufactured by Fagron, Inc. 2400 Pilot Knob Rd, St Paul, MN 55120, NDC 51552-1205-6.

by Fagron, Inc

Reason: Microbial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.
Published: August 6, 2014
Distribution: Nationwide

View recall →

Data last updated: October 3, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.